[1] Zou H, Ge Y, Lei Q, et al. Epidemiology and disease burden of non-alcoholic steatohepatitis in greater China: a systematic review[J]. Hepatol Int, 2022, 16(1): 27-37.
[2] Khan M Q, Hassan S, Lizaola-Mayo B C, et al. Navigating the "specific etiology" steatohepatitis category: Evaluation and management of nonalcohol/nonmetabolic dysfunction-associated steatohepatitis[J]. Hepatology, 2025, 82(2): 504-521.
[3] Takahashi Y. Nonalcoholic fatty liver disease and adult growth hormone deficiency: an under-recognized association?[J]. Best Pract Res Clin Endocrinol Metab, 2023, 37(6): 101816.
[4] Yuen K C J, Biller B M K, Radovick S, et al. American Association of Clincal Endocrinologists and American College of Endocrinologists Guidelines for Management of Growth Hormone Deficiency in Adults and Patients Transitioning from Pediatric to Adult Care[J]. Endocr Pract, 2019, 25(11): 1191-1232.
[5] Sinha R A, Bruinstroop E, Yen P M. Actions of thyroid hormones and thyromimetics on the liver[J]. Nat Rev Gastroenterol Hepatol, 2025, 22(1): 9-22.
[6] Yang Y, Qi Z, Zhang T, et al. Rapidly progressive non-alcoholic fatty liver disease due to hypopituitarism. Report of 5 cases[J]. Neuro Endocrinol Lett, 2018, 39(2): 99-104.
[7] Sarkar M, Yates K, Suzuki A, et al. Low testosterone is associated with nonalcoholic steatohepatitis and fibrosis severity in men[J]. Clin Gastroenterol Hepatol, 2021, 19(2): 400-402.
[8] Bhasin S, Brito J P, Cunningham G R, et al. Testosterone therapy in men with hypogonadism: An Endocrine Society Clinical Practice Guideline[J]. J Clin Endocrinol Metab, 2018, 103(5): 1715-1744.
[9] Doycheva I, Ehrmann D A. Nonalcoholic fatty liver disease and obstructive sleep apnea in women with polycystic ovary syndrome[J]. Fertil Steril, 2022, 117(5): 897-911.
[10] Smyk W, Papapostoli I, Zorniak M, et al. Liver phenotypes in PCOS: analysis of exogenous and inherited risk factors for liver injury in two European cohorts[J]. Liver Int, 2023, 43(5): 1080-1088.
[11] Sarkar M, Brady C W, Fleckenstein J, et al. Reproductive health and liver disease: Practice Guidance by the American Association for the Study of Liver Diseases[J]. Hepatology, 2021, 73(1): 318-365.
[12] Byrne J J, Seasely A, Nelson D B, et al. Comparing acute fatty liver of pregnancy from hemolysis, elevated liver enzymes, and low platelets syndrome[J]. J Matern Fetal Neonatal Med, 2022, 35(7): 1352-1362.
[13] Schilsky M L, Roberts E A, Bronstein J M, et al. A multidisciplinary approach to the diagnosis and management of Wilson disease: executive summary of the 2022 Practice Guidance on Wilson disease from the American Association for the Study of Liver Diseases[J]. Hepatology, 2023, 77(4): 1428-1455.
[14] Schilsky M L, Roberts E A, Bronstein J M, et al. A multidisciplinary approach to the diagnosis and management of Wilson disease: Executive summary of the 2022 Practice Guidance on Wilson disease from the American Association for the Study of Liver Diseases[J]. Hepatology, 2023, 77(4): 1428-1455.
[15] Khodayari N, Wang R L, Oshins R, et al. The mechanism of mitochondrial injury in alpha-1 antitrypsin deficiency mediated liver disease[J]. Int J Mol Sci, 2021, 22(24).
[16] Narayanan P, Mistry P K. Update on alpha-1 antitrypsin deficiency in liver disease[J]. Clin Liver Dis (Hoboken), 2020, 15(6): 228-235.
[17] Schilsky M L, Roberts E A, Bronstein J M, et al. A multidisciplinary approach to the diagnosis and management of Wilson disease: Executive summary of the 2022 Practice Guidance on Wilson disease from the American Association for the Study of Liver Diseases[J]. Hepatology, 2023, 77(4): 1428-1455.
[18] Martin-Escolano R, Virseda-Berdices A, Berenguer J, et al. Predictive plasma biomarkers of long-term increase in hepatic steatosis index after HCV eradication in HIV/HCV-coinfected patients[J]. Biomed Pharmacother, 2023, 164: 114913.
[19] Villa G, Owusu D, Smith C, et al. Liver steatosis and fibrosis in people with human immunodeficiency virus in West Africa and the relationship with hepatitis B virus coinfection[J]. Hepatol Commun, 2022, 6(11): 3036-3051.
[20] Wu H, Sang S, Weng P, et al. Structural, rheological, and gelling characteristics of starch-based materials in context to 3D food printing applications in precision nutrition[J]. Compr Rev Food Sci Food Saf, 2023, 22(6): 4217-4241. |
